Journal
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
Volume 14, Issue 1, Pages 1-11Publisher
JAPAN ATHEROSCLEROSIS SOC
DOI: 10.5551/jat.14.1
Keywords
oxidized low-density lipoprotein; ELISA; monoclonal antibody; AMI
Categories
Ask authors/readers for more resources
Oxidized low-density lipoprotein (OxLDL) has been shown to exist in human circulating plasma. Several groups including ours have developed methods for immunologically measuring OxLDL, which have been applied to several clinical, both cross-sectional and prospective, studies. These data clearly show that OxLDL levels correlate well with the severity of cardiovascular diseases. In particular, recent observations suggest that plasma OxLDL levels could be a useful marker for predicting future cardiovascular events; however, substantial differences exist among the different methods of OxLDL measurement. To evaluate the clinical data on circulating OxLDL, a proper understanding of the similarity, differences, and limitation of the methods is needed. This paper summarizes the characteristics of the methods used and recent clinical findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available